Premium
Monoamine precursors in the treatment of depression
Author(s) -
Carroll Bernard J.
Publication year - 1971
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1971125743
Subject(s) - monoamine neurotransmitter , tryptamine , norepinephrine , depression (economics) , serotonin , dopamine , psychiatry , medicine , psychology , pharmacology , neuroscience , economics , keynesian economics , receptor
The current biological theories of depression are united in postulating a role for brain monoamine deficiency in this group of disorders. The relative importance of the various amines, dopamine (DA), norepinephrine ( NE ), serotonin (5–HT ) and tryptamine, is still unsettled, and several versions of the monoamine deficit theory of depression have been put forward with emphasis on one or other of these compounds. 5 , 56 , 94 , 128